Welcome to our dedicated page for MetLife SEC filings (Ticker: MET), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MetLife, Inc. filings document the regulatory record of a Delaware financial services company with NYSE-listed common stock and preferred securities, including depositary shares tied to Series E and Series F preferred stock. Recent Form 8-K reports furnish earnings releases, quarterly financial supplements, total assets under management fact sheets and Regulation FD disclosures related to variable investment income.
The filings also cover capital-structure actions such as subordinated debenture issuance and preferred stock dividend declarations. Proxy materials describe board composition, committee assignments, executive compensation and shareholder voting matters, while material-event reports record governance changes and other corporate disclosures.
MetLife, Inc. filed a report confirming a previously announced first quarter 2026 dividend on its floating rate non-cumulative preferred stock, Series A. The dividend is $0.31501229 per share on shares with a $25 liquidation preference.
The company stated that the dividend will be payable on March 16, 2026, to shareholders of record as of Friday, February 27, 2026, because the normal record date of March 1, 2026 falls on a Sunday. The New York Stock Exchange had not yet set an ex-dividend date for the Series A preferred stock at the time of the announcement and is expected to set it following this confirmatory announcement.
MetLife Inc. executive John D. McCallion reported a tax-related share disposition. On March 2, 2026, 6,985 shares of MetLife common stock were withheld at $73.24 per share to cover taxes on vested restricted stock units. After this non-market transaction, he directly owned 275,194 shares.
MetLife Inc executive Shurawl Sibblies, EVP & Chief HR Officer, reported a tax-withholding disposition related to restricted stock units. On March 2, 2026, 220 shares of common stock were withheld at $73.24 per share for taxes, leaving her with 28,036 directly owned shares.
MetLife Inc. executive Marlene Debel, EVP & Chief Risk Officer, reported a tax-related share disposition. On the reported date, 4,133 shares of MetLife common stock were withheld to cover taxes on shares issued from restricted stock units. After this withholding, she directly held 154,380 shares.
MetLife Inc. President & CEO Michel Khalaf reported a tax-related share disposition tied to restricted stock units. On this Form 4, 22,420 shares of common stock were withheld at $73.24 per share to cover taxes, a non‑market transaction. After this withholding, he directly holds 697,709 shares of MetLife common stock.
MetLife executive Bill Pappas had 5,989 common shares withheld for taxes at $73.24 per share related to restricted stock units. After this tax-withholding disposition, he directly holds 83,746 common shares. He also reports indirect holdings of 10,220 shares in a 2024 GRAT and 18,750 shares in a 2025 GRAT.
MetLife Inc. executive Ramy Tadros reported a tax-related share disposition. On this Form 4, 5,166 shares of MetLife common stock were withheld on March 2, 2026 at $73.24 per share to cover taxes on shares issued from restricted stock units. After this withholding, Tadros directly holds 216,819 MetLife shares.
MetLife Inc.'s Executive Vice President and Chief Legal Officer, Monica M. Curtis, reported a tax-related share disposition on a Form 4. On March 2, 2026, 953 shares of MetLife common stock were withheld at $73.24 per share to cover taxes on shares issued from restricted stock units. After this tax-withholding disposition, she directly owned 17,646 shares of MetLife common stock.
MetLife (MET) reported proposed sales of Common Stock under a Form 144 filing. The notice lists multiple transactions dated between 12/17/2025 and 01/09/2026, with example recent sales including 562 shares on 01/09/2026 and 359 shares on 12/19/2025.
MetLife Inc. President, U.S. Business, Ramy Tadros reported stock-based compensation activity. He received 19,910 restricted stock units under a 2025 stock and incentive plan and 23,006 common shares from a 2023–2025 performance share award, deferring 80% of that payout. To cover taxes on the performance share payout, 2,299 shares were withheld at a price of $75.34 per share. After these awards and tax withholding, he directly owns 221,985 MetLife common shares.